ConductScience.org, home

Paper39440707

Enrichment for clinical trials of early AD: Combining genetic risk factors and plasma p-tau as screening instruments.

Wang X and 6 others. Alzheimers Dement, 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Enrichment for clinical trials of early AD: Combining genetic risk factors and plasma p-tau as screening instruments. Papers, record 39440707. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39440707

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Enrichment for clinical trials of early AD: Combining genetic risk factors and plasma p-tau as screening instruments.
PubMed
Journal
Alzheimers Dement
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.52, provisional
iCite
Revised in PubMed
2026-04-14
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang XXin
2Wang XXinran
3Edland SDSteven D
4Broce IJIris J
5Dale AMAnders M
6Banks SJSarah J
7Alzheimer's Disease Neuroimaging InitiativeGroup

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
tau ProteinsMajor topic
Cognitive DysfunctionMajor topic
Humans
Female
Male
Aged
Risk Factors
Clinical Trials as Topic
Biomarkers
Disease Progression
Phosphorylation
Aged, 80 and over

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U01 AG024904NIA NIH HHSUnited StatesU01AG024904PubMed and NIHNIH RePORTER
P30 AG062429NIA NIH HHSUnited StatesP30AG062429PubMedNIH RePORTER
R25 NS117367NINDS NIH HHSUnited StatesR25NS117367PubMedNIH RePORTER
R01 AG080663NIA NIH HHSUnited StatesR01AG080663PubMed and NIHNIH RePORTER
R01 AG066088NIA NIH HHSUnited StatesR01AG066088PubMed and NIHNIH RePORTER
1R01AG066088NIH HHSUnited StatesR01AG066088PubMed and NIHNIH RePORTER

Download CSV of grants

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136927491Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applications.Mol Neurodegener2023https://conductscience.org/library/papers/36927491PubMed
237012068Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function.J Neurol Neurosurg Psychiatry2023https://conductscience.org/library/papers/37012068PubMed
336745413Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers.JAMA Neurol2023https://conductscience.org/library/papers/36745413PubMed
433491853The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease.Alzheimers Dement2021https://conductscience.org/library/papers/33491853PubMed
536878697Potential Utility of Plasma P-Tau and Neurofilament Light Chain as Surrogate Biomarkers for Preventive Clinical Trials.Neurology2023https://conductscience.org/library/papers/36878697PubMed
634180956
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
JAMA Neurol2021https://conductscience.org/library/papers/34180956PubMed
724211008
Operationalizing hippocampal volume as an enrichment biomarker for amnestic mild cognitive impairment trials: effect of algorithm, test-retest variability, and cut point on trial cost, duration, and sample size.
Neurobiol Aging2014https://conductscience.org/library/papers/24211008PubMed
826379620Fluid Biomarkers in Clinical Trials of Alzheimer's Disease Therapeutics.Front Neurol2015https://conductscience.org/library/papers/26379620PubMed
929177679Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition.Acta Neuropathol2018https://conductscience.org/library/papers/29177679PubMed
1036701211A simple genetic stratification method for lower cost, more expedient clinical trials in early Alzheimer's disease: A preliminary study of tau PET and cognitive outcomes.Alzheimers Dement2023https://conductscience.org/library/papers/36701211PubMed
1133249783Plasma phosphorylated tau181 and neurodegeneration in Alzheimer's disease.Ann Clin Transl Neurol2021https://conductscience.org/library/papers/33249783PubMed
1222796873Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia.J Alzheimers Dis2012https://conductscience.org/library/papers/22796873PubMed
1335379951Early-stage Alzheimer disease: getting trial-ready.Nat Rev Neurol2022https://conductscience.org/library/papers/35379951PubMed
1439440707Enrichment for clinical trials of early AD: Combining genetic risk factors and plasma p-tau as screening instruments.Alzheimers Dement2024https://conductscience.org/library/papers/39440707PubMed
1533580752TOMM40-APOE haplotypes are associated with cognitive decline in non-demented Blacks.Alzheimers Dement2021https://conductscience.org/library/papers/33580752PubMed
1635496374Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratios.Alzheimers Dement (Amst)2022https://conductscience.org/library/papers/35496374PubMed
1727558378Enrichment of clinical trials in MCI due to AD using markers of amyloid and neurodegeneration.Neurology2016https://conductscience.org/library/papers/27558378PubMed
1832999917Enriching the design of Alzheimer's disease clinical trials: Application of the polygenic hazard score and composite outcome measures.Alzheimers Dement (N Y)2020https://conductscience.org/library/papers/32999917PubMed
1928721928Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers.Lancet Neurol2017https://conductscience.org/library/papers/28721928PubMed
2037694991The potential clinical value of plasma biomarkers in Alzheimer's disease.Alzheimers Dement2023https://conductscience.org/library/papers/37694991PubMed

See all 25 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42818907Rare extreme polygenic risk scores strongly indicate Alzheimer's disease risk.medRxiv2026https://conductscience.org/library/papers/42818907PubMed
42325556A dual space MRI radiomic network signature for risk stratification and subtyping of mild cognitive impairment.iScience2026https://conductscience.org/library/papers/42325556PubMed
41988903Clinical impact of the Alzheimer's Disease Neuroimaging Initiative: A review of studies using ADNI data (2023 to June 2025).Alzheimers Dement2026https://conductscience.org/library/papers/41988903PubMed
39440707Enrichment for clinical trials of early AD: Combining genetic risk factors and plasma p-tau as screening instruments.Alzheimers Dement2024https://conductscience.org/library/papers/39440707PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MAPT4137PubTator's text mininghttps://conductscience.org/library/genes/4137

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39440707

GET https://conductscience.org/api/papers/v1/39440707/references?page=2